(Q41521547)

2 October 2017

title

The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms (English)

1 reference

2 October 2017

1 reference

R Vanhoof

1

1 reference

2 October 2017

J M Hubrechts

2

1 reference

2 October 2017

E Roebben

3

1 reference

2 October 2017

H J Nyssen

4

1 reference

2 October 2017

E Nulens

5

1 reference

2 October 2017

J Leger

6

1 reference

2 October 2017

N De Schepper

7

1 reference

2 October 2017

publication date

1 November 1986

1 reference

2 October 2017

1 reference

2 October 2017

volume

14

1 reference

2 October 2017

issue

6

1 reference

2 October 2017

page(s)

294-298

1 reference

Yersinia enterocolitica: in vitro antimicrobial susceptibility

2 October 2017

cites work

1 reference

12 December 2020

Nalidixic-acid-resistant Shigella dysenteriae I

1 reference

12 December 2020

Antimicrobial susceptibility of Vibrio cholerae from Zaire and Rwanda

1 reference

12 December 2020

In-vitro susceptibility of salmonellae to antimicrobial agents.

1 reference

12 December 2020

In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics

1 reference

12 December 2020

Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

1 reference

12 December 2020

Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents

1 reference

12 December 2020

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

1 reference

12 December 2020

In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents

1 reference

12 December 2020

Antibiotic resistance of Salmonella in Europe and the United States

1 reference

12 December 2020

Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim

1 reference

12 December 2020

In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens

1 reference

12 December 2020

Treatment of Salmonella typhi carrier state with ciprofloxacin

1 reference

12 December 2020

Activity of bicozamycin (CGP 3543/E) on different enteropathogenic micro-organisms: comparison with other antimicrobial agents

1 reference

12 December 2020

Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents

1 reference

12 December 2020

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

1 reference

12 December 2020

Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents

1 reference

12 December 2020

Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01643966

1 reference

2 October 2017

1 reference